fenofibrate and n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide

fenofibrate has been researched along with n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aras-López, R; Arroyo-Villa, I; Balfagón, G; Blanco-Rivero, J; Ferrer, M; Márquez-Rodas, I; Xavier, FE	1

Other Studies

1 other study(ies) available for fenofibrate and n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide

Article	Year
Long-term fenofibrate treatment impairs endothelium-dependent dilation to acetylcholine by altering the cyclooxygenase pathway. Cardiovascular research, 2007, Jul-15, Volume: 75, Issue:2 Topics: Acetylcholine; Animals; Blotting, Western; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Endothelium, Vascular; Fenofibrate; In Vitro Techniques; Indomethacin; Male; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitrobenzenes; Prostaglandin-Endoperoxide Synthases; Prostaglandins F; Rats; Rats, Wistar; Sulfonamides; Time Factors; Vasodilation; Vasodilator Agents	2007

Article

Year

Long-term fenofibrate treatment impairs endothelium-dependent dilation to acetylcholine by altering the cyclooxygenase pathway.

Cardiovascular research, 2007, Jul-15, Volume: 75, Issue:2

Topics: Acetylcholine; Animals; Blotting, Western; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Endothelium, Vascular; Fenofibrate; In Vitro Techniques; Indomethacin; Male; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitrobenzenes; Prostaglandin-Endoperoxide Synthases; Prostaglandins F; Rats; Rats, Wistar; Sulfonamides; Time Factors; Vasodilation; Vasodilator Agents

2007